Rituximab for refractory and relapsing thrombotic thrombocytopenic purpura

被引：0
|
作者：
Knoebl, P. N. [1 ]
Distelmaier, P. [1 ]
Koder, S. [1 ]
Schellongowski, P. [1 ]
Quehenberger, P. [2 ]
机构：
[1] Med Univ Vienna, Med 1, Vienna, Austria
[2] Med Univ Vienna, Lab Med, Vienna, Austria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-077
引用
下载
收藏
页码：959 / 959
页数：1
相关论文
共 50 条
  • [41] CHRONIC RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA
    OZSOYLU, S
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1995, 12 (01) : 101 - 102
  • [42] Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: Case report
    Gianfaldoni, G
    Antonioli, E
    Mannelli, F
    Vannucchi, AM
    Bosi, A
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (04) : 449 - 451
  • [43] Long-Term Response to Rituximab in Patients with Relapsing Thrombotic Thrombocytopenic Purpura
    Stein, Gideon Y.
    Blickstein, Dorit
    Orlin, Jerome
    Sarig, Galit
    Inbal, Aida
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (07): : 398 - 401
  • [44] Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases
    Koulova, L
    Alexandrescu, D
    Dutcher, JP
    O'Boyle, KP
    Eapen, S
    Wiernik, PH
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (01) : 49 - 54
  • [45] Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study
    de la Rubia, Javier
    Moscardo, Federico
    Gomez, Maria J.
    Guardia, Ramon
    Rodriguez, Pilar
    Sebrango, Ana
    Zamora, Concepcion
    Deben, Guillermo
    Goterris, Rosa
    Lopez, Rafaela
    Pena, Francisco
    Pujol, Misericordia
    Vidaller, Antonio
    del Rio-Garma, Julio
    Sanz, Miguel A.
    TRANSFUSION AND APHERESIS SCIENCE, 2010, 43 (03) : 299 - 303
  • [46] Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib
    Patel, Priyank P.
    Becker, Joanne
    Freyer, Craig
    Griffiths, Elizabeth
    Thompson, James E.
    Wang, Eunice S.
    TRANSFUSION, 2016, 56 (04) : 970 - 974
  • [47] Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report
    Chaurasiya, Prem Shankar
    Khatri, Akash
    Gurung, Shekhar
    Karki, Saurab
    Shahi, Sunil
    Aryal, Laxmi
    ANNALS OF MEDICINE AND SURGERY, 2022, 82
  • [48] Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature
    Montoya, Roberto C.
    Poiesz, Bernard J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (04) : 338 - 341
  • [49] Successful use of rituximab and plasma exchange in the treatment of refractory thrombotic thrombocytopenic purpura
    Reddy, RL
    Silberstein, PT
    TRANSFUSION, 2005, 45 (03) : 39A - 39A
  • [50] High activity of rituximab for treatment of relapsed/refractory thrombotic thrombocytopenic purpura.
    Reddy, P
    Deauna-Limayo, D
    Bodensteiner, DB
    Cook, JD
    Ganguly, SS
    Skikne, BS
    BLOOD, 2003, 102 (11) : 802A - 802A
12345